Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Cangrelor

Brand: 
NICE TA: 351 (terminated)
Indication: Reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (NICE TA351 - terminated appraisal)
Disease category: Cardiovascular system
Commissioning responsibility: CCG
PbR excluded: No

Background

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Black

Black

Black

Black

Black

Black